🇺🇸 FDA
Patent

US 8697138

Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders

granted A61KA61K31/202A61K31/215

Quick answer

US patent 8697138 (Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders) held by Aker Biomarine AS expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aker Biomarine AS
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/202, A61K31/215, A61K31/683, A61K35/612